KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Net Income: 2018-2025

Historic Net Income for Castle Biosciences (CSTL) over the last 8 years, with Sep 2025 value amounting to -$501,000.

  • Castle Biosciences' Net Income fell 122.08% to -$501,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 300.86%. This contributed to the annual value of $18.2 million for FY2024, which is 131.75% up from last year.
  • As of Q3 2025, Castle Biosciences' Net Income stood at -$501,000, which was down 110.99% from $4.6 million recorded in Q2 2025.
  • Castle Biosciences' Net Income's 5-year high stood at $9.6 million during Q4 2024, with a 5-year trough of -$29.2 million in Q1 2023.
  • Over the past 3 years, Castle Biosciences' median Net Income value was -$2.5 million (recorded in 2024), while the average stood at -$5.5 million.
  • As far as peak fluctuations go, Castle Biosciences' Net Income slumped by 1,039.38% in 2023, and later surged by 471.71% in 2024.
  • Over the past 5 years, Castle Biosciences' Net Income (Quarterly) stood at -$6.4 million in 2021, then crashed by 220.65% to -$20.6 million in 2022, then surged by 87.49% to -$2.6 million in 2023, then soared by 471.71% to $9.6 million in 2024, then tumbled by 122.08% to -$501,000 in 2025.
  • Its Net Income was -$501,000 in Q3 2025, compared to $4.6 million in Q2 2025 and -$25.8 million in Q1 2025.